Furthermore, enhanced expression of FUTs observed in cancers can contribute to MDR development by activating the PI3K/Akt and extracellular signal-regulated kinase (ERK)/MAPK pathways, which facilitate the survival of cells and compromise the efficacy of anticancer therapies [154,155]. Here, AKT1 is linked to cancer.